Fundz

DatAIMed raises €1.2M from Maggioli Group for clinical AI platform expansion. The Turin-based startup strengthens its evidence-based healthcare knowledge system.

PRIVATEOct 27, 2026

Amount Raised

€1.2 Million

Round Type

Seed

TurinBiotechnologyHealth CareArtificial Intelligence

Investors

Maggioli Group

Description

DatAIMed, a Turin-based clinical AI startup, has secured €1.2 million in funding through a capital increase from Maggioli Group, which acquired a 20% stake in the company. The platform provides European healthcare professionals with evidence-based artificial intelligence for clinical knowledge and continuing medical education. DatAIMed's system allows natural language queries and returns concise summaries linked to verifiable sources from international biomedical literature and institutional references. The funding will support the expansion of the platform's adoption across European healthcare systems.

Quick answer

DatAIMed raised €1.2 Million in a Seed round, dated October 27, 2026. Investors: Maggioli Group. DatAIMed is based in Turin, Piedmont, Italy.

How much did DatAIMed raise?
DatAIMed raised €1.2 Million in a Seed round on October 27, 2026.
Who invested in DatAIMed?
Maggioli Group is named as investors in this round.
What does DatAIMed do?
DatAIMed is a Turin-based startup that has built a European, evidence-based artificial intelligence platform for clinical knowledge and continuing medical education.
Where is DatAIMed based and how big is it?
DatAIMed is based in Turin, Piedmont, Italy. Fundz records about 10 employees.
Who are the decision-makers at DatAIMed?
Fundz holds 3 contacts at DatAIMed, including the Founder | CEO. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as DatAIMed that raised within 45 days of this round, from Fundz verified event records.

  • Orakl Oncology raised $34M (Series A) on November 12, 2026.
  • Switchpoint Bio raised $5.3M (Pre-Seed) on November 11, 2026.
  • Kardi Ai raised $5.9M (Series A) on November 11, 2026.
  • Alterra Labs raised $13M (Seed) on November 10, 2026.
  • Mosaic Intelligence Labs raised $47M (Seed) on November 10, 2026.
  • Vale Biolabs raised $183K (Pre-Seed) on November 9, 2026.

Who to call at DatAIMed, and when

A new round usually means DatAIMed is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day DatAIMed raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at DatAIMed, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at DatAIMed. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

DatAIMed

Location

Turin, Piedmont, Italy

About

DatAIMed is a Turin-based startup that has built a European, evidence-based artificial intelligence platform for clinical knowledge and continuing medical education. The platform allows healthcare professionals to ask questions in natural language and receive concise summaries linked to verifiable sources from international biomedical literature and institutional references. It can integrate internal protocols from healthcare facilities and ensures GDPR compliance by hosting infrastructure and data within the EU. The platform aims to streamline access to research, guidelines, and documents while supporting better-informed clinical decisions.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment DatAIMed raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

3 contacts
Verified contactsDario, Founder | CEO hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for DatAIMed's next move

See what Strategic adds

DatAIMed raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.